Pancreatic Cancer Research

ResearcherUniversity of TorontoActive in the last 2 years

Andrew A. Beharry

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1505-2375; OpenAlex author ID A5085065543. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Ratiometric Fluorescent Chemosensing for Predicting Response to Irinotecan-Based Therapies in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1021/acssensors.5c04552↗
  2. Measuring human carboxylesterase 2 activity in pancreatic cancer patient-derived xenografts using a ratiometric fluorescent chemosensor. Last author DOI 10.1039/c9sc00283a↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Karishma Kailass · 2 shared papers, 2019–2026 · strength 0.41
  2. Jason B. Fleming · 2 shared papers, 2019–2026 · strength 0.41
  3. Bhaswati Sarcar · 1 shared paper, 2026 · strength 0.30
  4. Jennifer B. Permuth · 1 shared paper, 2026 · strength 0.30
  5. Michela Capello · 1 shared paper, 2019 · strength 0.11
  6. Ya’an Kang · 1 shared paper, 2019 · strength 0.11
  7. Samir Hanash · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.